New lab models of photoreceptor loss to speed up cell-based treatments
A two-pronged approach to generating novel models of photoreceptor degeneration for regenerative cell therapy
Researchers are creating two types of lab models of photoreceptor damage to help develop cell-replacement therapies for people with inherited retinal diseases like retinitis pigmentosa and Leber congenital amaurosis.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Baylor College of Medicine NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11163485 on NIH RePORTER |
What this research studies
As someone with an inherited retinal disease, you should know researchers are building two complementary lab models of photoreceptor loss: a quick laser-induced injury model and a slower, gene-edited progressive degeneration model. They will transplant human stem-cell-derived photoreceptors into these models to see if the cells survive, integrate, and connect to the visual system. The goal is to learn which approaches best support long-term survival and functional connections before trying them in people. This work is being done at Baylor to help move safer, better-informed cell therapies toward clinical testing.
Who could benefit from this research
Good fit: People with advanced photoreceptor loss from inherited retinal diseases (for example, retinitis pigmentosa or Leber congenital amaurosis) would be the eventual candidates for the therapies this research aims to enable.
Not a fit: Patients whose vision loss is mainly from optic nerve or brain causes, or those seeking immediate treatments, are unlikely to get direct benefit from this preclinical lab project.
Why it matters
Potential benefit: If successful, this work could make cell-replacement treatments for inherited retinal diseases safer and more likely to restore vision.
How similar studies have performed: Prior lab studies have shown human stem-cell-derived retinal cells can survive and integrate in acute laser injury models, but extending that success to progressive, gene-based disease models is a newer effort.
Where this research is happening
Houston, United States
- Baylor College of Medicine — Houston, United States (Active)
Researchers
- Principal investigator: Fu, Yingbin — Baylor College of Medicine
- Study coordinator: Fu, Yingbin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.